Results 111 to 120 of about 24,524 (277)

Trends in Second‐Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population‐Based Study, 2019–2024

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To assess contemporary UK trends in second‐line treatment initiations and outcomes across age‐and‐frailty groups in people with type 2 diabetes (T2D). Materials and Methods We studied 117 046 UK adults with T2D initiating second‐line therapy between 2019–2024 (Clinical Practice Research Datalink).
M. M. Dinsdale   +11 more
wiley   +1 more source

Characterization of sulfonylurea receptors in isolated human pancreatic islets

open access: yes, 1998
Current information on pancreatic islet sulfonylurea receptors has been obtained with laboratory animal pancreatic beta cells or stable beta-cell lines.
GIANNACCINI, GINO   +8 more
core   +1 more source

Patterns and Trends of Glucose‐Lowering Therapy in Alzheimer's Disease and Related Dementias

open access: yes
Diabetes, Obesity and Metabolism, EarlyView.
Huilin Tang   +7 more
wiley   +1 more source

Aerobic Exercise Training Increases Circulating sRAGE in Adults With Type 2 Diabetes: Associations With Sheddase Regulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Objective Soluble receptor for advanced glycation end‐products (sRAGE) and soluble Toll‐like receptor 4 (sTLR4) are circulating pattern recognition receptor isoforms implicated in inflammatory regulation in type 2 diabetes mellitus (T2DM). This study examined the effects of supervised aerobic exercise training (AET) on circulating sRAGE, sTLR4,
Ryan K. Perkins   +9 more
wiley   +1 more source

SALSA® (Ethametsulfuron-methjyl 75% WG): A novel selective herbicide for oilseed rape in Europe

open access: yesJulius-Kühn-Archiv, 2012
SALSA® is a novel selective herbicide in oilseed rape for the control of important broadleaved weeds postemergence in fall. EU registration is applied for at 25 g/ha + surfactant (Trend 90).
Drobny, Hans G., Schlang, Norbert
doaj   +1 more source

Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT‐1 and SURMOUNT‐2 Trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Obesity affects over 800 million people globally and is associated with complications including cardiovascular disease and type 2 diabetes (T2D). Early response to weight loss interventions may help optimize achievement of individual treatment goals.
Alexander Kokkinos   +7 more
wiley   +1 more source

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives

open access: yes, 2011
OBJECTIVE Numerous studies have suggested a decreased risk of cancer in patients with diabetes on metformin. Because different comparison groups were used, the effect magnitude is difficult to estimate. Therefore, the
Bruno H.Ch. Stricker   +8 more
core   +1 more source

One Week Exposure to a Somatostatin Receptor 2 Antagonist (SSTR2a) Enhances Glucagon Counterregulation to Insulin‐Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin‐Requiring Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Introduction Administration of a somatostatin receptor 2 antagonist (SSTR2a) increases glucagon responsiveness to hypoglycaemia in insulin‐treated type 2 diabetes (T2D), but the durability of this effect and the impact of repeated SSTR2a dosing on overall glycaemia in T2D are unclear.
Ninoschka C. D'Souza   +7 more
wiley   +1 more source

Monitoring the Occurrence of Sulfonylurea-Resistant Prickly Lettuce (Lactuca serriola)

open access: yes, 1992
Sulfonylurea herbicide-resistant prickly lettuce was discovered in Idaho in 1987. The objectives of these surveys were to determine the change with time in the proportion of sulfonylurea resistant and susceptible prickly lettuce biotypes on the farm ...
Carol Mallory-Smith   +2 more
core   +1 more source

Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Importance Clinical guidelines for type 2 diabetes (T2D) provide population‐level recommendations, but real‐world treatment patterns evolve dynamically and vary across patients. Understanding longitudinal prescribing trajectories may reveal heterogeneity in care not captured by cross‐sectional analyses.
Tobias S. Lux   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy